Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Brainhole Technology Limited ( (HK:2203) ) has shared an announcement.
Brainhole Technology Limited has expanded its investment positions by purchasing additional shares in AOI and AXT on 13 March 2026, investing about US$0.6 million in each counter through open-market transactions. On the same day, it also realized gains and rebalanced its portfolio by disposing of Nebius shares for approximately US$1.5 million, continuing its active management of listed equity holdings.
The company confirmed that, when aggregated with earlier purchases within 12 months, the AOI and AXT acquisitions reach total considerations of about US$1.9 million and US$1.8 million respectively, triggering discloseable transaction status under Hong Kong Listing Rules. While each latest trade is not individually notifiable, their combined size crosses the 5% threshold, requiring public reporting and underscoring the growing scale of Brainhole’s securities investment activities.
The most recent analyst rating on (HK:2203) stock is a Hold with a HK$0.20 price target. To see the full list of analyst forecasts on Brainhole Technology Limited stock, see the HK:2203 Stock Forecast page.
More about Brainhole Technology Limited
Brainhole Technology Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, is an investment holding company that actively trades listed securities as part of its capital management strategy. The company allocates funds to equity positions in overseas issuers, reflecting a focus on portfolio investment and securities trading activities.
Average Trading Volume: 1,679,228
Technical Sentiment Signal: Sell
Current Market Cap: HK$152M
See more data about 2203 stock on TipRanks’ Stock Analysis page.